Advertisement

Topics

Dr. Fenning BioMed GmbH Company Profile

22:48 EDT 21st September 2017 | BioPortfolio

As a Contract Research Organization (CRO) our goal is to support our customers in the design, conduct and analysis of their clincial trials.

Location

Ottenstrasse 1
Kirchzarten
D-79199
Germany

Contact

Phone: 49 7661 9331 0
Fax: 49 7661 9331 11
Email: manfred.koehler@koehler-freiburg.de


News Articles [279 Associated News Articles listed on BioPortfolio]

LA BioMed researcher honored for contributions to medicine

(LA BioMed) The Medical Mycology Society of the Americas has honored John E. "Jack" Edwards, Jr., MD, an LA BioMed lead researcher, as the winner of the 2017 Rhoda Benham Award

Q BioMed partners with Sphaera for pediatric developmental nonverbal disorder

Q BioMed (QBIO), a biotechnology acceleration company, announced a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder. &#...

HanAll Biopharma and Harbour BioMed link up on biologicals development in Greater China

South Korea’s HanAll Biopharma (009420: KS) and Massachusetts, USA-based Harbour BioMed have entered…

Prima BioMed Carves A Niche In Busy IO Pipeline

Emerging Company Profile: Prima BioMed, a biotech developing immuno-oncology medicines, has been patiently waiting in the wings. Now, with three...   

THC BioMed Receives Financing Commitment of up to $12 Million from Alumina Partners - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - August 15, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) has received a financing commitment of up to $12 million from Alumina Partners LLC...

THC BioMed Closes Acquisition of US-Based Clone Shipper at Cost of US$1 Million - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - May 9, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHC) has closed its previously announced acquisition of U.S. based Clone Shipper LLC, acqui...

Prima BioMed To Get 2nd Milestone Payment From Novartis For IMP701 Program

BASEL (dpa-AFX) - Prima BioMed Ltd (PRR.AX, PBMD)announced late Sunday that it will receive a second undisclosed significant clinical milestone payment from Novartis (NVS). The payment is based on...

THC BioMed Receives First Order to Export Dried Marijuana to Germany - Video Available on InvestmentPitch.com

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) has received its first order to export dried marijuana to Germany. The company, an a...

PubMed Articles [60 Associated PubMed Articles listed on BioPortfolio]

Determination of VH Family Usage in B-Cell Malignancies via the BIOMED-2 IGH PCR Clonality Assay.

To determine whether V H family usage in B-cell lymphoproliferative disorders can be deduced from polymerase chain reaction (PCR) product-length information obtained through the BIOMED-2 (Invivoscribe...

Diagnostic Significance of BIOMED-2 Standardized Gene Rearran-gement System in Patients with Non-Hodgkin's Lymphoma.

To detect the immunoglobulin(Ig) and T cell receptor(TCR) gene rearrangement in bone marrow of non-Hodgkin's lymphoma(NHL) patients by using BIOMED-2 standardized system, and to explore the potential ...

The Role of Publishers in Prevention of Misconducts in Medical Research: Springer and BioMed Central, Victim or Culprit.

Corrigendum to "Comparative tissue distribution and excretion study of alkaloids from Herba Ephedrae-Radix Aconiti Lateralis extracts in rats" J. Pharm. Biomed. Anal., 134 (2017) 137-142.

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Clinical Trials [42 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [562 Associated Companies listed on BioPortfolio]

Dr. Fenning BioMed GmbH

As a Contract Research Organization (CRO) our goal is to support our customers in the design, conduct and analysis of their clincial trials.

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

Alpine Biomed Corporation

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux diseas...

More Information about "Dr. Fenning BioMed GmbH" on BioPortfolio

We have published hundreds of Dr. Fenning BioMed GmbH news stories on BioPortfolio along with dozens of Dr. Fenning BioMed GmbH Clinical Trials and PubMed Articles about Dr. Fenning BioMed GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dr. Fenning BioMed GmbH Companies in our database. You can also find out about relevant Dr. Fenning BioMed GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...


Corporate Database Quicklinks



Searches Linking to this Company Record